Ben Lakhal, Raihane <br/><br/>
Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience).  [electronic resource] 

 -  Annals of hematology  Apr 2018 
 - 597-604 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-017-3224-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate--adverse effects<br/>Leukemia, Myeloid, Accelerated Phase--diagnosis<br/>Leukemia, Myeloid, Chronic-Phase--diagnosis<br/>Male<br/>Middle Aged<br/>Practice Patterns, Physicians'<br/>Prognosis<br/>Protein Kinase Inhibitors--adverse effects<br/>Retrospective Studies<br/>Splenomegaly--etiology<br/>Survival Analysis<br/>Tumor Burden--drug effects<br/>Tunisia--epidemiology<br/>Young Adult